What’s on Sanofi’s M&A list now that Medivation is gone? Catalyst gets an SPA; Adaptimmune partners with Merck
As we’ve said before at Endpoints News, this has been a rough year for Sanofi $SNY. Now that Medivation has slipped through its fingers, falling …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
